SIRT1 and cardiovascular disorder: However, these preliminary results suggest that 4 can be considered a valid candidate as an SIRT1 activator, and it may be worth investing in its characterization and the design of its derivatives, paving the way for a new class of SIRT1 activators potentially interesting for the treatment/prevention of cardiovascular diseases.